Your browser is no longer supported. Please, upgrade your browser.
ASLN ASLAN Pharmaceuticals Limited weekly Stock Chart
ASLN [NASD]
ASLAN Pharmaceuticals Limited
Index- P/E- EPS (ttm)-1.29 Insider Own- Shs Outstand37.99M Perf Week27.15%
Market Cap72.40M Forward P/E- EPS next Y-0.50 Insider Trans- Shs Float36.90M Perf Month19.25%
Income-43.90M PEG- EPS next Q-0.07 Inst Own9.20% Short Float0.39% Perf Quarter-9.43%
Sales- P/S- EPS this Y-5.20% Inst Trans2.03% Short Ratio1.65 Perf Half Y64.10%
Book/sh-0.23 P/B- EPS next Y-25.00% ROA-190.20% Target Price- Perf Year4.92%
Cash/sh0.37 P/C5.17 EPS next 5Y- ROE- 52W Range0.35 - 8.18 Perf YTD-5.42%
Dividend- P/FCF- EPS past 5Y- ROI-283.20% 52W High-76.53% Beta-
Dividend %- Quick Ratio3.20 Sales past 5Y- Gross Margin- 52W Low448.57% ATR0.12
Employees- Current Ratio3.20 Sales Q/Q- Oper. Margin- RSI (14)75.86 Volatility10.52% 8.12%
OptionableNo Debt/Eq- EPS Q/Q59.70% Profit Margin- Rel Volume4.56 Prev Close1.66
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume86.32K Price1.92
Recom2.30 SMA2027.72% SMA5018.45% SMA2006.98% Volume393,713 Change15.71%
Jan-14-19Reiterated H.C. Wainwright Buy $12 → $8.50
Sep-21-20 06:00AM  
Sep-10-20 03:08AM  
Aug-24-20 03:27AM  
Aug-07-20 03:00AM  
Jul-17-20 06:08AM  
Jul-13-20 12:00PM  
08:06AM  
Jun-25-20 08:50AM  
Jun-19-20 05:50PM  
Jun-11-20 12:00PM  
Jun-04-20 09:46PM  
May-11-20 05:34AM  
May-07-20 05:50PM  
Apr-20-20 08:56AM  
Apr-13-20 04:21AM  
Mar-26-20 12:00PM  
Mar-18-20 05:18AM  
Feb-24-20 02:05AM  
Feb-20-20 05:50PM  
Feb-10-20 05:45PM  
Feb-04-20 05:45PM  
Jan-28-20 10:39AM  
Jan-27-20 11:30AM  
Jan-15-20 04:34PM  
08:22AM  
Jan-14-20 08:53AM  
Jan-13-20 12:00PM  
Jan-06-20 12:04PM  
Dec-18-19 09:58AM  
06:57AM  
Dec-05-19 06:22PM  
Dec-03-19 02:29PM  
07:59AM  
01:00AM  
Dec-02-19 01:34PM  
12:50PM  
07:51AM  
02:07AM  
Nov-22-19 08:18AM  
01:30AM  
Nov-11-19 12:36PM  
07:09AM  
03:21AM  
Nov-08-19 09:00AM  
Nov-06-19 11:00AM  
10:34AM  
Oct-31-19 03:37AM  
Oct-22-19 02:45AM  
Oct-18-19 03:35AM  
Oct-02-19 02:30AM  
Sep-30-19 02:35AM  
Sep-19-19 03:50AM  
Sep-10-19 05:14AM  
Aug-27-19 06:00AM  
Aug-13-19 04:03AM  
Jul-31-19 04:14AM  
Jul-26-19 04:20AM  
Jul-01-19 09:00AM  
Jun-04-19 08:00AM  
May-31-19 03:15AM  
May-10-19 04:15AM  
May-06-19 09:00AM  
Apr-29-19 05:02AM  
Mar-29-19 12:13PM  
05:50AM  
Mar-28-19 10:41AM  
Mar-22-19 07:25AM  
Mar-11-19 03:00AM  
Feb-26-19 05:35PM  
Jan-29-19 05:40PM  
Jan-23-19 01:35AM  
Jan-14-19 06:34PM  
05:44PM  
09:46AM  
Jan-13-19 05:30PM  
Jan-04-19 02:00AM  
Jan-02-19 03:48AM  
Dec-02-18 12:00PM  
Nov-27-18 04:47AM  
Nov-20-18 05:00AM  
Nov-08-18 06:05AM  
Nov-01-18 10:20AM  
Oct-30-18 03:54AM  
Oct-22-18 07:00AM  
Oct-17-18 12:31PM  
Oct-09-18 06:15AM  
Sep-21-18 04:00AM  
Sep-17-18 06:58AM  
Sep-04-18 02:47AM  
Aug-20-18 02:49AM  
Aug-10-18 08:19AM  
Aug-06-18 04:05AM  
Jul-03-18 04:01AM  
May-30-18 01:47PM  
08:35AM  
May-17-18 02:25AM  
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and a small molecule inhibitor targeting oncology. Its partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.